S2Medical AB (S2M) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.068x

Based on the latest financial reports, S2Medical AB (S2M) has a cash flow conversion efficiency ratio of 0.068x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr676.00K ≈ $72.75K USD) by net assets (Skr9.88 Million ≈ $1.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See S2M equity financing ratio to measure how much of total assets are equity-financed.

S2Medical AB - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how S2Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check S2M operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

S2Medical AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of S2Medical AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
STMicroelectronics NV
LSE:0INB
0.221x
Keramika Indonesia Assosiasi
JK:KIAS
0.007x
Galileo Tech Ltd
TA:GLTC
0.023x
Upsellon Brands Holdings Ltd
TA:CHR
0.180x
Reliance Industries Limited
IL:RIGD
N/A
Trade & Value AG
HM:TAV
N/A
Onfolio Holdings Inc
NASDAQ:ONFO
0.000x
Cobra Resources PLC
LSE:COBR
-0.060x

Annual Cash Flow Conversion Efficiency for S2Medical AB (2016–2025)

The table below shows the annual cash flow conversion efficiency of S2Medical AB from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see market value of S2Medical AB.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr9.88 Million
≈ $1.06 Million
Skr675.00K
≈ $72.64K
0.068x -83.97%
2024-12-31 Skr11.80 Million
≈ $1.27 Million
Skr5.03 Million
≈ $541.40K
0.426x +104.28%
2023-12-31 Skr1.66 Million
≈ $178.42K
Skr-16.52 Million
≈ $-1.78 Million
-9.964x -150.39%
2022-12-31 Skr7.07 Million
≈ $760.76K
Skr-28.13 Million
≈ $-3.03 Million
-3.979x -197.08%
2021-12-31 Skr14.68 Million
≈ $1.58 Million
Skr-19.67 Million
≈ $-2.12 Million
-1.339x -244.25%
2020-12-31 Skr32.77 Million
≈ $3.53 Million
Skr-12.75 Million
≈ $-1.37 Million
-0.389x +42.87%
2019-12-31 Skr25.11 Million
≈ $2.70 Million
Skr-17.10 Million
≈ $-1.84 Million
-0.681x -132.57%
2018-12-31 Skr43.55 Million
≈ $4.69 Million
Skr-12.75 Million
≈ $-1.37 Million
-0.293x +63.05%
2017-12-31 Skr7.38 Million
≈ $793.67K
Skr-5.85 Million
≈ $-629.12K
-0.793x +28.05%
2016-12-31 Skr2.75 Million
≈ $296.05K
Skr-3.03 Million
≈ $-326.18K
-1.102x --

About S2Medical AB

ST:S2M Sweden Medical Instruments & Supplies
Market Cap
$522.23K
Skr4.85 Million SEK
Market Cap Rank
#30901 Global
#729 in Sweden
Share Price
Skr0.01
Change (1 day)
+3.85%
52-Week Range
Skr0.00 - Skr0.02
All Time High
Skr1000000.00
About

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and… Read more